| 1. |
|
|
| 2. |
- Abbafati, Cristiana, et al.
(författare)
-
- 2020
-
Tidskriftsartikel (refereegranskat)
|
|
| 3. |
- Arya, Ashwani, et al.
(författare)
-
Acetylcholinesterase Inhibitory Potential of Various Sesquiterpene Analogues for Alzheimer's Disease Therapy
- 2021
-
Ingår i: Biomolecules. - : MDPI AG. - 2218-273X. ; 11:3
-
Forskningsöversikt (refereegranskat)abstract
- Alzheimer’s disease (AD) is a gradually growing irreversible illness of the brain that almost affects every fifth person (aged > 80 years) in the world. World Health Organization (WHO) also revealed that the prevalence of this disease will enhance (upto double) significantly upto 2030. The poor cholinergic transmission at the synapse is considered to be one of the main reasons behind the progression and occurrence of this disorder. Natural inhibitors of acetylcholine (ACh) such as galanthamine and rivastigmine are used commercially in the treatmentof AD. The biomolecules such assesquiterpenes, possess a great structural diversity and are responsible for a plethora of pharmacological properties. The potential of various sesquiterpenes as anticholinesterase has been reviewed in this article. For this purpose, the various databases, mainly PubMed, Scopus, and Web of Science were investigatedwith different keywords such as “sesquiterpenes+acetylcholinesterase” and “sesquiterpenes+cholinesterase+inhibitors” in the surveyed time frame (2010–2020). A vast literature was evident in the last decade, which affirms the potential of various sesquiterpenes in the improvement of cholinergic transmission by inhibiting the AChE. After data analysis, it was found that 12 compounds out of a total of 58 sesquiterpenes were reported to possess IC50 < 9 μM and can be considered as potential candidates for the improvement of learning and memory. Sesquiterpene is an important category of terpenoids, found to possess a large spectrum of biological activities. The outcome of the review clearly states that sesquiterpenes (such as amberboin, lipidiol, etc.) from herbs could offer fresh, functional compounds for possible prevention and treatment of AD.
|
|
| 4. |
- Jayakumar, O. D., et al.
(författare)
-
Experimental and theoretical investigations on magnetic behavior of (Al,Co) co-doped ZnO nanoparticles
- 2010
-
Ingår i: Nanoscale. - : Royal Society of Chemistry (RSC). - 2040-3364 .- 2040-3372. ; 2:8, s. 1505-1511
-
Tidskriftsartikel (refereegranskat)abstract
- We present the structural and magnetic properties of Zn0.95-xCo0.05AlxO (x = 0.0 to 0.1) nanoparticles, synthesized by a novel sol-gel route followed by pyrolysis. Powder X-ray diffraction data confirms the formation of a single phase wurtzite type ZnO structure for all the compositions. The Zn0.95Co0.05O nanoparticles show diamagnetic behavior at room temperature. However, when Al is co-doped with Co with x = 0.0 to 0.10 in Zn0.95-xCo0.05AlxO, a systematic increase in ferromagnetic moment is observed up to x = 0.07 at 300 K. Above x = 0.07 (e.g. for x = 0.10) a drastic decrease in ferromagnetic nature is observed which is concomitant with the segregation of poorly crystalline Al rich ZnO phase as evidenced from TEM studies. Theoretical studies using density functional calculations on Zn0.95-xCo0.05AlxO suggest that the partial occupancy of S2 states leads to an increased double exchange interaction favoring the ferromagnetic ground states. Such ferromagnetic interactions are favorable beyond a threshold limit. At a high level doping of Al, the exchange splitting is reduced, which suppresses the ferromagnetic ordering.
|
|
| 5. |
- Muvva, Jagadeeswara Rao, et al.
(författare)
-
Immunomodulatory Agents Combat Multidrug-Resistant Tuberculosis by Improving Antimicrobial Immunity
- 2021
-
Ingår i: Journal of Infectious Diseases. - : Oxford University Press. - 0022-1899 .- 1537-6613. ; 224:2, s. 332-344
-
Tidskriftsartikel (refereegranskat)abstract
- Background. Multidrug-resistant (MDR) tuberculosis has low treatment success rates, and new treatment strategies are needed. We explored whether treatment with active vitamin D-3 (vitD) and phenylbutyrate (PBA) could improve conventional chemotherapy by enhancing immune-mediated eradication of Mycobacterium tuberculosis. Methods. A clinically relevant model was used consisting of human macrophages infected with M. tuberculosis isolates (n = 15) with different antibiotic resistance profiles. The antimicrobial effect of vitD+PBA, was tested together with rifampicin or isoniazid. Methods included colony-forming units (intracellular bacterial growth), messenger RNA expression analyses (LL-37, beta-defensin, nitric oxide synthase, and dual oxidase 2), RNA interference (LL-37-silencing in primary macrophages), and Western blot analysis and confocal microscopy (LL-37 and LC3 protein expression). Results. VitD+PBA inhibited growth of clinical MDR tuberculosis strains in human macrophages and strengthened intracellular growth inhibition of rifampicin and isoniazid via induction of the antimicrobial peptide LL-37 and I,C3-dependent autophagy. Gene silencing of LL-37 expression enhanced MDR tuberculosis growth in vitD+PBA-treated macrophages. Me combination of vitD+PBA and isoniazid were as effective in reducing intracellular MDR tuberculosis growth as a >125-fold higher dose of isoniazid alone, suggesting potent additive effects of vitD+PBA with isoniazid. Conclusions. Immunomodulatory agents that trigger multiple immune pathways can strengthen standard MDR tuberculosis treatment and contribute to next-generation individualized treatment options for patients with difficult-to-treat pulmonary tuberculosis.
|
|
| 6. |
- Patel, Vinay, et al.
(författare)
-
Development of vascular cambium in the leaf rachis of Kigelia Africana (Lam.) Benth
- 2010
-
Ingår i: PRAJÑĀ - Journal of Pure and Applied Sciences. - Gujarat, India : Sardar Patel University. - 0975-2595. ; 18:1-4, s. 40-43
-
Tidskriftsartikel (refereegranskat)abstract
- The structural changes during the vascular cambium development from procambium in the leaf rachis of Kigelia africana bearing leaflets of different developmental stages (young, mature and old rachis) were investigated. The different regions from the internodes of rachis bearing young, copper brown coloured leaves revealed the sequential stages of cambial development. Terminal region of the rachis showed developing procambium along with protoxylem and protopholem derivatives, middle regions exhibited the development of interfascicular cambium whereas basal region showed complete ring of vascular cambium with secondary phloem derivatives. Rachis bearing brownish coloured leaflets showed an active cambium with both secondary xylem and phloem derivatives indicating bidirectional cambial growth. Rachis with fully matured dark green leaflets was characterized by the presence of dormant cambium surrounded by mature xylem and phloem elements and occurrence of calcium oxalate crystals in the phloem parenchyma cells. The study also describes the pattern of vascular cambial development in the leaf rachis of Kigelia, a deciduous tree and it was compared with development of vascular cambium in the leaves of conifers and evergreen dicotyledons. Influence of leaf maturity on cambial activity and secondary xylem development is discussed.
|
|
